{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T03:01:03Z","timestamp":1780282863815,"version":"3.54.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04833-2","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:26:40Z","timestamp":1776677200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influencing factors of chemotherapy-induced peripheral neuropathy in colorectal cancer: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Mengting","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"3","key":"4833_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4833_CR2","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386\u2013422.","journal-title":"Ann Oncol"},{"key":"4833_CR3","doi-asserted-by":"crossref","unstructured":"Barathan M, Zulpa AK, Ng SL, Lokanathan Y, Ng MH, Law JX. Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytochemicals and Extracellular Vesicles. Int J Mol Sci. 2024;25(13).","DOI":"10.3390\/ijms25137470"},{"issue":"1","key":"4833_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2015.11.011","volume":"140","author":"JR Brewer","year":"2016","unstructured":"Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecol Oncol. 2016;140(1):176\u201383.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"4833_CR5","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","volume":"268","author":"L Kang","year":"2021","unstructured":"Kang L, Tian Y, Xu S, Chen H. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol. 2021;268(9):3269\u201382.","journal-title":"J Neurol"},{"issue":"1","key":"4833_CR6","first-page":"33","volume":"30","author":"C Teng","year":"2022","unstructured":"Teng C, Cohen J, Egger S, Blinman PL, Vardy JL. Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer. Support Care Cancer. 2022;30(1):33\u201347.","journal-title":"Support Care Cancer"},{"issue":"4","key":"4833_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/0284186X.2014.980912","volume":"54","author":"AJ Beijers","year":"2015","unstructured":"Beijers AJ, Mols F, Tjan-Heijnen VC, Faber CG, van de Poll-Franse LV, Vreugdenhil G. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry. Acta Oncol. 2015;54(4):463\u20139.","journal-title":"Acta Oncol"},{"issue":"1","key":"4833_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.annonc.2020.10.480","volume":"32","author":"K Yamazaki","year":"2021","unstructured":"Yamazaki K, Yamanaka T, Shiozawa M, Manaka D, Kotaka M, Gamoh M, Shiomi A, Makiyama A, Munemoto Y, Rikiyama T, et al. Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial. Ann Oncol. 2021;32(1):77\u201384.","journal-title":"Ann Oncol"},{"issue":"1","key":"4833_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11764-021-00988-x","volume":"17","author":"HC Timmins","year":"2023","unstructured":"Timmins HC, Mizrahi D, Li T, Kiernan MC, Goldstein D, Park SB. Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review. J Cancer Surviv. 2023;17(1):222\u201336.","journal-title":"J Cancer Surviv"},{"key":"4833_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"9","key":"4833_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"04","key":"4833_CR12","first-page":"297","volume":"4","author":"X Zeng","year":"2012","unstructured":"Zeng X, Liu H, Chen X, Leng W. Meta-analysis series IV: quality assessment tools for observational studies. Chin J Evid Based Cardiovasc Med. 2012;4(04):297\u20139.","journal-title":"Chin J Evid Based Cardiovasc Med"},{"issue":"1","key":"4833_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12876-025-03734-0","volume":"25","author":"X Cheng","year":"2025","unstructured":"Cheng X, Zhang P, Jiang D, Fang B, Chen F. Safety and efficacy of ciprofol versus propofol for gastrointestinal endoscopy: a meta-analysis. BMC Gastroenterol. 2025;25(1):130.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"4833_CR14","first-page":"Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"4833_CR15","first-page":"30","volume":"22","author":"Y Bian","year":"2024","unstructured":"Bian Y, Ding Y, Xie F, Lv J, Chen Y, Xu Z. Effect of different nutritional status on oxaliplatin-inducedperipheral neurotoxicity(OlPN) incolorectal cancer patients. Cent South Pharm. 2024;22(01):30\u20135.","journal-title":"Cent South Pharm"},{"issue":"5","key":"4833_CR16","first-page":"1313","volume":"21","author":"B Vincenzi","year":"2013","unstructured":"Vincenzi B, Frezza AM, Schiavon G, Spoto C, Silvestris N, Addeo R, Catalano V, Graziano F, Santini D, Tonini G. Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV. Support Care Cancer. 2013;21(5):1313\u20139.","journal-title":"Support Care Cancer"},{"issue":"09","key":"4833_CR17","first-page":"1479","volume":"38","author":"X Wei","year":"2022","unstructured":"Wei X, Lin J, Ye F, Cai S, Wu Q, Cheng F, Yang Y, Wang Y. Construction and application of risk prediction model of oxaliplatin induced peripheral neuropathy. J Mod Med Health. 2022;38(09):1479\u201382.","journal-title":"J Mod Med Health"},{"issue":"17","key":"4833_CR18","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.7314\/APJCP.2015.16.17.7603","volume":"16","author":"A Shahriari-Ahmadi","year":"2015","unstructured":"Shahriari-Ahmadi A, Fahimi A, Payandeh M, Sadeghi M. Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran. Asian Pac J Cancer Prev. 2015;16(17):7603\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4833_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000442527","volume":"90","author":"A Ottaiano","year":"2016","unstructured":"Ottaiano A, Nappi A, Tafuto S, Nasti G, De Divitiis C, Romano C, Cassata A, Casaretti R, Silvestro L, Avallone A, et al. Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy. Oncology. 2016;90(1):36\u201342.","journal-title":"Oncology"},{"issue":"5","key":"4833_CR20","first-page":"1383","volume":"25","author":"H Tanishima","year":"2017","unstructured":"Tanishima H, Tominaga T, Kimura M, Maeda T, Shirai Y, Horiuchi T. Hyperacute peripheral neuropathy is a predictor of oxaliplatin-induced persistent peripheral neuropathy. Support Care Cancer. 2017;25(5):1383\u20139.","journal-title":"Support Care Cancer"},{"key":"4833_CR21","unstructured":"Sheng F. Study on the relationship between the risk of chemotherapy-induced peripheral neuropathy and diabetes. M.S. Thesis. China Medical University; 2019."},{"issue":"4","key":"4833_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/COC.0b013e318246b50d","volume":"36","author":"LM Alejandro","year":"2013","unstructured":"Alejandro LM, Behrendt CE, Chen K, Openshaw H, Shibata S. Predicting acute and persistent neuropathy associated with oxaliplatin. Am J Clin Oncol. 2013;36(4):331\u20137.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"4833_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/jnnp-2013-305334","volume":"85","author":"R Velasco","year":"2014","unstructured":"Velasco R, Bruna J, Briani C, Argyriou AA, Cavaletti G, Alberti P, Frigeni B, Cacciavillani M, Lonardi S, Cortinovis D, et al. Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. J Neurol Neurosurg Psychiatry. 2014;85(4):392\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"4833_CR24","first-page":"4781","volume":"28","author":"N Yildirim","year":"2020","unstructured":"Yildirim N, Cengiz M. Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin. Support Care Cancer. 2020;28(10):4781\u20138.","journal-title":"Support Care Cancer"},{"key":"4833_CR25","doi-asserted-by":"publisher","first-page":"1642552","DOI":"10.3389\/fonc.2025.1642552","volume":"15","author":"M Salama","year":"2025","unstructured":"Salama M, Barnes D, Georghiou A, Murad M, Almalki S, Ahmed Z, Openshaw MR, Palles C, Tuxworth RI. Anti-oxidative stress therapies prevent severe chemotherapy-induced peripheral neuropathy in colorectal cancer patients treated with oxaliplatin: a systematic review and meta-analysis. Front Oncol. 2025;15:1642552.","journal-title":"Front Oncol"},{"issue":"2","key":"4833_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21037\/apm-24-154","volume":"14","author":"N Rahman","year":"2025","unstructured":"Rahman N, Sukumar J, Lustberg MB. Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments. Ann Palliat Med. 2025;14(2):196\u2013216.","journal-title":"Ann Palliat Med"},{"key":"4833_CR27","doi-asserted-by":"publisher","first-page":"175628642412527","DOI":"10.1177\/17562864241252718","volume":"17","author":"E Ege","year":"2024","unstructured":"Ege E, Briggi D, Vu P, Cheng J, Lin F, Xu J. Targeting dorsal root ganglia for chemotherapy-induced peripheral neuropathy: from bench to bedside. Ther Adv Neurol Disord. 2024;17:17562864241252718.","journal-title":"Ther Adv Neurol Disord"},{"key":"4833_CR28","doi-asserted-by":"crossref","unstructured":"Karlsson JOG, Jynge P. Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca(4)Mn(DPDP)(5), MnDPDP and DPDP. Int J Mol Sci. 2024;25(8).","DOI":"10.3390\/ijms25084347"},{"issue":"2","key":"4833_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ygyno.2018.12.002","volume":"152","author":"HW Bulls","year":"2019","unstructured":"Bulls HW, Hoogland AI, Kennedy B, James BW, Arboleda BL, Apte S, Chon HS, Small BJ, Gonzalez BD, Jim HSL. A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer. Gynecol Oncol. 2019;152(2):310\u20135.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4833_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/SPC.0000000000000536","volume":"15","author":"J Crimmin","year":"2021","unstructured":"Crimmin J, Fulop T, Battisti NML. Biological aspects of aging that influence response to anticancer treatments. Curr Opin Support Palliat Care. 2021;15(1):29\u201338.","journal-title":"Curr Opin Support Palliat Care"},{"key":"4833_CR31","doi-asserted-by":"crossref","unstructured":"von Itzstein MS, Rashdan S, Dahlberg SE, Gerber DE, Sandler AB, Schiller JH, Johnson DH, Wang Y, Sun Z, Ramalingam SS. Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer. Oncologist. 2025;30(3).","DOI":"10.1093\/oncolo\/oyaf036"},{"issue":"9","key":"4833_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11892-017-0903-2","volume":"17","author":"P Zhu","year":"2017","unstructured":"Zhu P, Pan XF, Sheng L, Chen H, Pan A. Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action. Curr Diab Rep. 2017;17(9):78.","journal-title":"Curr Diab Rep"},{"issue":"6","key":"4833_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.clinthera.2018.04.001","volume":"40","author":"Z Iqbal","year":"2018","unstructured":"Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, Lim J, Malik RA, Alam U. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clin Ther. 2018;40(6):828\u201349.","journal-title":"Clin Ther"},{"issue":"6","key":"4833_CR34","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman EL, Nave KA, Jensen TS, Bennett DLH. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron. 2017;93(6):1296\u2013313.","journal-title":"Neuron"},{"issue":"5","key":"4833_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/emmm.201100134","volume":"3","author":"J Descoeur","year":"2011","unstructured":"Descoeur J, Pereira V, Pizzoccaro A, Francois A, Ling B, Maffre V, Couette B, Busserolles J, Courteix C, Noel J, et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med. 2011;3(5):266\u201378.","journal-title":"EMBO Mol Med"},{"issue":"12","key":"4833_CR36","first-page":"7461","volume":"29","author":"J Gu","year":"2021","unstructured":"Gu J, Lu H, Chen C, Gu Z, Hu M, Liu L, Yu J, Wei G, Huo J. Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Support Care Cancer. 2021;29(12):7461\u20139.","journal-title":"Support Care Cancer"},{"key":"4833_CR37","doi-asserted-by":"crossref","unstructured":"Wesselink E, Winkels RM, van Baar H, Geijsen A, van Zutphen M, van Halteren HK, Hansson BME, Radema SA, de Wilt JHW, Kampman E et al. Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients. Nutrients. 2018;10(4).","DOI":"10.3390\/nu10040398"},{"issue":"1","key":"4833_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12035-025-05463-7","volume":"63","author":"J Du","year":"2025","unstructured":"Du J, Sudlow LC, Shahverdi K, Zhou H, Yuede CM, Crock LW, Hunter DA, Golden J, Mollah SA, Wood MD, et al. Chronic Oxaliplatin Treatment Induces CIPN in Mice via Activation of the TXNIP Pathway. Mol Neurobiol. 2025;63(1):92.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"4833_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/0284186X.2014.995775","volume":"54","author":"M Ewertz","year":"2015","unstructured":"Ewertz M, Qvortrup C, Eckhoff L. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol. 2015;54(5):587\u201391.","journal-title":"Acta Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04833-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04833-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04833-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:20:39Z","timestamp":1780280439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04833-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04833-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study is a secondary analysis of previously published literature, ethical approval and patient consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}